Loading
Ovarian Function and Disorders · Journal article
International Journal of Molecular Sciences · September 8, 2026
Raises a question worth testing. It does not answer one.
This narrative review proposes BMAL1 dysregulation as a candidate unifying mechanism linking obesity to reduced IVF success through impaired oocyte competence and altered endometrial receptivity. The evidence is drawn primarily from rodent models, cultured cell systems, and observational human cohorts; direct causal evidence in humans is explicitly acknowledged as lacking. The authors present this as a mechanistic hypothesis for future testing rather than an established or actionable clinical mechanism.
Narrative review. Women of reproductive age undergoing or considered for IVF; obese women; donor-oocyte cycle recipients..
Obesity reduces IVF success rates; molecular basis remains fragmented BMAL1 loss of rhythmicity in granulosa cells impairs mitochondrial biogenesis and increases reactive oxygen species, compromising oocyte competence Obese women in donor-oocyte cycles show reduced implantation rates in several but not all cohorts, compatible with endometrial contribution distinct from oocyte-level damage
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians should regard BMAL1 dysregulation as an emerging mechanistic hypothesis rather than an established explanation for obesity-related IVF failure. Chronotherapeutic interventions such as melatonin supplementation or weight-loss timing are not currently supported as clinical recommendations and require direct human validation before adoption.
This is a mechanistic review synthesizing evidence largely from rodent models and cultured systems to propose BMAL1 dysregulation as a unifying mechanism; direct causal evidence in humans is acknowledged as lacking, and clinical data are only consistent with, not proof of, the proposed dual mechanism.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians should regard BMAL1 dysregulation as an emerging mechanistic hypothesis rather than an established explanation for obesity-related IVF failure. Chronotherapeutic interventions such as melatonin supplementation or weight-loss timing are not currently supported as clinical recommendations and require direct human validation before adoption.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Obesity affects nearly one in three women of reproductive age worldwide and consistently reduces success rates in in vitro fertilization, yet the molecular basis for this reduction remains fragmented across separate lines of evidence. Circadian clock genes, particularly BMAL1, orchestrate metabolic and reproductive physiology through transcription–translation feedback loops present in adipose tissue, ovarian granulosa cells, and endometrial stroma. Adiposity-driven metabolic shifts, including altered PPAR-γ signaling and reduced glutamine–methionine uptake, degrade BMAL1 expression and flatten its rhythmic oscillation in peripheral tissues. Within granulosa cells, loss of BMAL1 rhythmicity impairs mitochondrial biogenesis and disrupts UPRmt-mediated proteostasis, driving reactive oxygen species accumulation and compromising oocyte competence. Parallel disruption of clock-controlled transcription factors in endometrial epithelium and stroma is proposed to alter decidualization programs and displace the window of implantation, which would produce a receptivity defect independent of oocyte quality if confirmed directly in human tissue. Clinical data are consistent with a dual mechanism: obese women undergoing donor-oocyte cycles—where oocyte quality is controlled for—show reduced implantation rates in several but not all cohorts—a pattern compatible with an endometrial contribution distinct from oocyte-level damage, rather than proof of it. Synthesizing evidence from adipocyte biology, ovarian physiology, and endometrial receptivity research drawn largely from rodent models, cultured cell systems, and observational human cohorts, this review proposes BMAL1 dysregulation as a candidate unifying mechanism connecting obesity to impaired IVF outcomes at the gametic and uterine level, while acknowledging that direct causal evidence in humans is still lacking. Chronotherapeutic strategies, including melatonin supplementation and the timing of weight-loss interventions relative to ovarian stimulation, are discussed as hypotheses for future testing rather than current clinical recommendations. BMAL1 dysregulation is presented here as one candidate contributor among several interacting mechanisms, and any translational strategy would need to be part of a broader, coordinated approach to obesity-related IVF failure rather than a stand-alone intervention.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.